The landscape of blood sugar treatment is evolving with the arrival of transdermal GLP-1 delivery . These novel patches offer a possibly more comfortable alternative to needle administrations for individuals living with diabetes 2. Such a system deliver a GLP-1 agonist directly through the epidermis, bypassing the requirement for daily injection… Read More